We are live on
!
Find out more
SCA
Stokes Capital Advisors Portfolio holdings
AUM
$467M
1-Year Est. Return
14.84%
This Fund
S&P 500
This Quarter
Est. Return
+2.21%
1 Year Est. Return
+14.84%
3 Year Est. Return
+54.54%
5 Year Est. Return
+73.74%
10 Year Est. Return
–
AUM
$294M
AUM Growth
+$4.1M
(+1.4%)
Cap. Flow
+$6.14K
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
27.41%
Holding
87
New
2
Increased
33
Reduced
36
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Tower
AMT
|
+$2.56M |
| 2 |
Stryker
SYK
|
+$1.73M |
| 3 |
Colgate-Palmolive
CL
|
+$1.36M |
| 4 |
Mastercard
MA
|
+$725K |
| 5 |
UnitedHealth
UNH
|
+$605K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$3.32M |
| 2 |
Roper Technologies
ROP
|
+$3.01M |
| 3 |
Ecolab
ECL
|
+$557K |
| 4 |
Casey's General Stores
CASY
|
+$526K |
| 5 |
Steris
STE
|
+$491K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 14.39% |
| 2 | Technology | 13.51% |
| 3 | Consumer Staples | 12.07% |
| 4 | Financials | 11.4% |
| 5 | Healthcare | 11.07% |
Similar funds
PC
HP
JHC
UC
VCM
SP
KWS
LN
Stokes Capital Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Stokes Capital Advisors held 87 positions worth $294M, up 1.4% from $290M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Stokes Capital Advisors's Q1 2023 filing shows 2 new, 33 increased, 36 reduced and 6 closed positions. Its largest new stake was American Tower: 12,190 shares worth $2.49M. The largest sale was Pfizer, an estimated $3.32M.
By sector, the portfolio is most concentrated in Industrials at 14% of assets, down from 15% a quarter earlier, followed by Technology and Consumer Staples.
- Stokes Capital Advisors's largest Q1 2023 buy was American Tower: 12,190 shares worth $2.49M.
- Stokes Capital Advisors added most to Stryker in Q1 2023, an estimated $1.73M increase.
- Stokes Capital Advisors's biggest Q1 2023 reduction was Roper Technologies, cutting an estimated $3.01M.
- Stokes Capital Advisors fully exited Pfizer in Q1 2023, selling an estimated $3.32M.
- Stokes Capital Advisors's ten largest holdings make up 27% of its $294M portfolio in Q1 2023.
- Stokes Capital Advisors opened 2 new positions and closed 6 in Q1 2023.
- Stokes Capital Advisors's portfolio value rose 1.4% quarter-over-quarter to $294M.
Based on Stokes Capital Advisors's 13F filing for Q1 2023, filed 12 Apr 2023.